Wright Medical Group, Inc.
|
|
- Roberta Chapman
- 6 years ago
- Views:
Transcription
1 Wright Medical Group, Inc. A Global Orthopaedic Medical Device Company We are a global orthopaedic medical device company specializing in the design, manufacture, and marketing of reconstructive joint devices and biologics. Wright's product offerings include large joint implants for the hip and knee; extremity implants for the hand, elbow, shoulder, foot and ankle; and both synthetic and tissue-based bone graft substitute materials. 1
2 Wright Medical Group, Inc. Two Fundamentally Solid Platforms EXTREMITIES and BIOLOGICS ORTHO-RECON 40% 60% 2
3 Foot & Ankle Product Portfolio - Most comprehensive & innovative SIDEKICK Fixation GRAFTJACKET Ulcer Repair Matrix VALOR NAIL Fixation CHARLOTTE Jones Fracture Screw DARCO Screws CHARLOTTE CLAW CHARLOTTE CLAW 3.5mm Implant 2.7mm Implant CHARLOTTE Compression SIDEKICK Stealth Fixation INBONE Total Ankle AM Surgical Endoscopic Blade CHARLOTTE 7.0 MUC Screw BIOFOAM Wedge ORTHOLOC Plate LIS FRANC Plate CHARLOTTE 3.0 MUC Screw DART-FIRE Screws ORTHOSPHERE Implant CHARLOTTE Snap-Off Screw DARCO DPS Plate BIO-ARCH Implant ORTHOLOC Plate SWANSON Hammer Toe Implant ENDO-FUSE Rods and Beams DARCO PIA Plate DARCO LPS Plate DARCO BOW Plate DARCO MPJ Plate LPT Toe Implant SWANSON Great Toe CORETRAK Tube Fixator MTP Plate DARCO RPS Plate 3
4 Upper Extremity Product Portfolio - Legacy Leadership In Niche Segments GRAFTJACKET Graft SWANSON Finger Implant EVOLVE Plate MICRONAIL Implant RAYHACK Ulnar Shortening RAYHACK Radial Malunion EVOLVE Implant 4
5 Ortho Recon Innovative Knee Portfolio ADVANCE Medial Pivot 10+ Years of clinical success Medial-Pivot Kinematics MIS Instrumentation Cementless Fixation Patient-Specific Instruments 5
6 Ortho Recon Innovative Hip Portfolio Modular Hip Systems Innovative & Comprehensive Acetabular Systems Resurfacing & BFH Modularity Bearing Options CONSERVE PLUS Total Hip Resurfacing CONSERVE Total with BFH Technology Hip System Confidence with Stability. DYNASTY Acetabular with BIOFOAM CANCELLOUS TITANIUM 6
7 BACKUP SLIDES 7
8 Quality System Global Quality System Certifications Ø ISO 13485:2003 Ø ISO 9001:2008 AATB Accredited Tissue Bank FDA Establishment Registration #
9 Quality System Overview Quality Policy We will meet or exceed the expectations of our customers by complying with requirements, by maintaining the effectiveness of the quality management system, by training employees, and by designing and building quality into our products.
10 Quality Manual
11 FDA Initiatives Fostering Device Innovation DeNovo reforms to the regulatory pathway for lower-risk novel devices with no 510k option, but which do not warrant the PMA requirement for higher-risk devices 510(k) program reform: CDRH plan to incorporate new scientific information into regulatory decision making Draft guidance on Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device Refuse to Accept Guidance E-Copy Draft FDA Guidance Implementation of UDI in labeling
12 Recent Trends Approval Challenges 510(k) Standard of care in question Slower reviews- Spending total review time allowed before generating additional questions Increase in 510(k) conversion (Specialà Traditional) based on supportive data (eg. Test data, adverse event reports) Additional scrutiny of pre-clinical data Device intended for use in Class II and Class III applications must be split into 2 separate 510k filings. Ex. Hip 510ks now require duplicate filings (MoM vs MoP, CoP) Reviewers recent enforcement related to E- Copy and Refuse to Accept Draft Guidance Historical performance (Corrective Fixes)
13 Corrective Fixes Fixes made and intent to launch Device launched Adverse events w/ root cause Not eligible as Special 510k since data review req d How to address corrective fix in the filing? Typically want sponsor to be able to replicate the failure mode observed clinically Demonstrate that comparatively the modified device should not fail in similar capacity Demonstrate that subject device is equivalent to nondefective device Original device recalled, obsoleted, or continued to be sold
14 Pre- Clinical Data Bench testing not demonstrating equiv. to predicate. Subject not performing as well. New patient population within scope of intended use/ indications for use (possibly a specific indication for use) New technological characteristics that may have clinical impact (e.g. device affects surrounding bones) Device performs below level of predicate device on the bench and clinical ramifications are not known/ cannot be predicted in an animal model
15 Recent Trends Approval Challenges 510(k) Letter to the File Device modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device 1997 Guidance vague and requires interpretation 2011 draft guidance was closed for comments, but later dropped by FDA Fewer changes qualify - Ex. Sizes outside of cleared range require 510k regardless of worst case determination FDA scrutiny of LTF process expected during Quality audits
16 Recent Trends Approval Challenges 510(k) LTF Instruments Enforcement of inclusion in PMA /510k filing Unique instruments take on classification of device:
17 Recent Trends Approval Challenges 510(k) LTF Instruments Customs Strict FDA interpretation of current guidance One-of-a-kind device limited to physician or dentist If another company makes device, it is generally available / not custom Device that could be used for >1 patient is not custom Modification to an existing device (shorter, fatter, left-handed, etc) is customized, not custom, and requires a pre-market submission Burden of proof lies with manufacturer Increase of Compassionate Use requests to due to strict interpretation of policy. New guidance delayed by FDA
18 Recent Trends Approval Challenges 510(k) LTF Instruments Customs Labeling Lack of FDA guidance for new communication methods (eg. Social Media guidance delayed) General vs Specific claims Text Requirement in Device Labeling All symbols on outer package label must be accompanied by text on the outer package label. Fair & balanced promo Final guidance on the implementation of UDI
19 International Trends Country of Origin identification Limited Global government resources (reviewers) Re-registration of devices licensed before early 2000 s causing approval delays (Latin America) Increased requests for additional data to support new product registrations and license renewals Strict adherence to test standards (mechanical, biocompatibility of final implants) EU: New regulations to impact CE Marking Canada: Uncertainty from Health Canada regarding licensing of instruments (regulations vague on grouping ) 19
20 Wright Initiatives Review of company-wide policies and procedures to ensure continued compliance to evolving regulations (domestic and global) Delays in review have required the adjust of internal timelines for new product launches, as well as global renewals Review and streamline of product portfolio. Product redeployment initiated for R.O.W. markets. Communication with FDA to enlist least burdensome approach for UDI implementation Active involvement with industry groups (eg. AdvaMed, OSMA)
Investor Presentation. November 26, 2013
Investor Presentation November 26, 2013 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws. These statements reflect management's
More informationRE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationStandards and Regulatory Considerations for Orthopaedic Implants
Standards and Regulatory Considerations for Orthopaedic Implants Constituencies Patients Payers (Insurance) Physicians Manufacturers Research Community Government Legal Community Professional Organizations
More informationMarch 6, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org March 6, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration
More informationRE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System
November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:
More informationDRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011
Draft Guidance for Industry and Food and Drug Administration Staff The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] DRAFT GUIDANCE This guidance document is being
More informationCurrent Trends at FDA: Implications for Data Requirements
Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
More informationU.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE. Jeff Shuren Director Center for Devices and Radiological Health
U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health 21 st Century Cures Implementation Establish Breakthrough Device Pathway Change
More informationMurray Sheldon, MD Associate Director for Technology and Innovation Center for Devices and Radiological Health (CDRH) Office of the Center Director
Murray Sheldon, MD Associate Director for Technology and Innovation Center for Devices and Radiological Health (CDRH) Office of the Center Director The National Academies Innovation Policy Forum September
More informationFDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond
FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond Jeff Shuren, MD, JD Center for Devices and Radiological Health U.S. Food and Drug Administration May 4, 2017 1
More informationJanuary 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 3, 2017 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure
More informationMEDICAL DEVICE GUIDANCE
Effective from 1 January 2013 MEDICAL DEVICE GUIDANCE GN-15: Guidance on Medical Device Product Registration Revision 5 CONTENTS 1. INTRODUCTION... 4 1.1. Scope... 5 1.2. Definitions... 5 2. RISK CLASSIFICATION
More information2013 May expect UDI Final Rule. This put a date on when the draft of the proposed rule had to be released
2011 Global Harmonization Task Force (GHTF) UDI Guidance published 2012 FDA Proposed Regulation Publishes 2012 FDA Safety and Innovation Act (FDASIA) provisions added This put a date on when the draft
More informationMedSC 2014 Spring Meeting. Managing Field and Consignment Inventory. June 4, 2014
MedSC 2014 Spring Meeting Managing Field and Consignment Inventory Industry trends and drivers for transformation 1 Health Reform & 2 Growth Outside 3 Mergers & 4 Cost Pressures the U.S. Acquisitions Regulatory
More informationJP Morgan Healthcare Conference. 11 January 2010
JP Morgan Healthcare Conference 11 January 2010 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform
More informationINSIDE SYNTELLIX THE COMPANY BEHIND GAME CHANGING INNOVATIONS. Intelligent innovations for a better life.
INSIDE SYNTELLIX THE COMPANY BEHIND GAME CHANGING INNOVATIONS Intelligent innovations for a better life. www.syntellix.com SMALL SCREW GREAT SUCCESS. NEUE PRESSE HANOVER () THIS SCREW IS A MEDICAL SENSATION.
More informationGet to market. You want to develop medical devices that are safe, effective, and compliant. We ll show you the most efficient path.
Get to market. You want to develop medical devices that are safe, effective, and compliant. We ll show you the most efficient path. Clinical Research Services We ve been the world s leading medical device
More informationWhite Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014
White Paper: Improvements to the Australian Regulatory System for Medical Devices 23 May 2014 mtaa.org.au Medical technology for a healthier Australia 0 www.mtaa.org.au Level 12, 54 Miller St, North Sydney
More informationUnderstanding Clinical Equivalence
Understanding Clinical Equivalence BSI 2014 Medical Device Mini-Roadshow Ibim Tariah Ph.D Technical Director, Healthcare Solutions 1 Understanding Clinical Equivalence Review Requirements from Directives
More informationGETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR)
GETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR) Caroline Leab Abbott Director of Regulatory Affairs David Wolf PTC Program Director of Medical Device Strategy liveworx.com NEW
More informationPrecision in fixation
For more information, visit Medartis at www.medartis.com or contact us directly: Medartis AG Hochbergerstrasse 60E CH-4057 Basel P +41 61 633 34 34 F +41 61 633 34 00 www.medartis.com Precision in fixation
More informationNew creative textile construction using innovative braiding technology and materials
White Paper New creative textile construction using innovative braiding technology and materials DSM and Meister Provide Foundation for Medical Device Design Philippe Gédet, Engineer, Meister & Cie AG
More informationDeciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff
Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff Document issued on October 25, 2017. The draft of this document was issued
More informationApril 7, 2016 VIA ELECTRONIC MAIL
April 7, 2016 VIA ELECTRONIC MAIL Patricia Brooks, RHIA Centers for Medicare and Medicaid Services CMM, HAPG, Division of Acute Care Mail Stop C4-08-06 7500 Security Boulevard Baltimore, Maryland 21244-1850
More informationCompliance Central: CDRH 2017 Trends and 2018 Priorities
Compliance Central: CDRH 2017 Trends and 2018 Priorities CAPT Sean M. Boyd, MPH, USPHS Deputy Director for Regulatory Affairs CDRH Office of Compliance Assessing Benefit-Risk Benefit Risk Other Factors
More informationAbbreviated WHO prequalification assessment procedure
Abbreviated WHO prequalification assessment procedure Industry Briefing on Streamlined WHO Prequalification of Diagnostics Procedure 15/16 May 2014, Geneva Anita Sands Prequalification Team Diagnostics
More informationRe: Docket No. FDA-2009-D-0179, Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org July 27, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationClinical Integration Track: It s All About the Data
Clinical Integration Track: It s All About the Data Presenters: Sandi Michel, Director of Systems & Quality The Office of Data Standards & Interoperability Franciscan Missionaries of Our Lady Health System
More informationThe GS1 System and services (GTIN, GLN and GDSN) can be used to comply with this rule.
Department of Health and Human Services Food and Drug Administration Unique Device Identification System Proposed Rule Executive summary On Tuesday, July 10, 2012 the Food and Drug Administration issued
More informationDe Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff
De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff Document issued on October 30, 2017. The draft of this document
More information8 Steps towards EU-MDR implementation
8 Steps towards EU-MDR implementation Gert Bos Executive director & Partner A global leading medical device consultancy group Europe - Amsterdam (HQ) USA - Boston - San Francisco China Nanjing Copyright
More informationUDI 101: What You Need to Know About Unique Device Identifiers
UDI 101: What You Need to Know About Unique Device Identifiers Lena Cordie Qualitas Professional Services 2015 Qualitas Professional Services. All rights reserved. Presentation Objectives: Understanding
More informationThe Arcam EBM process: A walkthrough
The Arcam EBM process: A walkthrough 2012-06-13 1 Overview Arcam & EBM Process Design for EBM EBM - Core Benefits Validating EBM 2012-06-13 2 Arcam Swedish innovation from the beginning of the 1990 s Arcam
More informationTST Medical Devices. company profile
TST Medical Devices company profile WE ARE LOOKING FORWARD TO THE FUTURE, ANTICIPATING CUSTOMERS NEEDS AND COMING UP WITH SOLUTIONS. We are offering quality and value. We strive for continuous improvment.
More informationExpanded Access and the Individual Patient IND
Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office
More informationTop 10. Changing Enforcement Environment. The Fourth Annual Medical Device Regulatory, Reimbursement and Compliance Congress November 10, 2009
The Fourth Annual Medical Device Regulatory, Reimbursement and Compliance Congress November 10, 2009 Roundtable on the Top 10 Device Manufacturer-FDA Regulatory Issues Dorothy J. Clarke, Esq., Vice President,
More informationTrabecular Metal Acetabular Revision System Cup-Cage Construct
Trabecular Metal Acetabular Revision System Cup-Cage Construct Surgical Technique The Best Thing Next to Bone Trabecular Metal Acetabular Revision System Cup-Cage Construct Trabecular Metal Acetabular
More informationCopyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.
Statutory Framework for Devices Medical Devices Investigational Use Application IDE (21 CFR 812) Abbreviated IDE Exempt Pre-Market Approval Applications 510(k) Pre-marketing Notification (21 CFR 807(e))
More informationMedical Device Single Audit Program (MDSAP) An Overview Canadian Experience
Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : 360-817-5556 : linda.chatwin@ul.com LINDA M CHATWIN, Esq, RAC Biography Ms.
More informationPerspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm
Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction As precision
More informationBy: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS
AN INTRODUCTION TO THE WORLDWIDE REGULATORY FRAMEWORK FOR MEDICAL DEVICES By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS COURSE OUTLINE /
More informationSoftware Regulation: The Transfusion Medicine Experience
AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin
More informationThe implications of the new EU Medical Device Regulation on Combination Product Packaging
The implications of the new EU Medical Device Regulation on Combination Product Packaging June 2017 ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com
More informationCDRH Pilot Activities
CDRH Pilot Activities Cisco Vicenty Program Manager, Case for Quality 1 Office of Compliance, CDRH November 15, 2017 VCIP Voluntary Compliance Improvement Program Pilot Status Description: Assessment:
More informationAccelerated Capital Allowances Eligibility Criteria. Category: Process and Heating, Ventilation and Air conditioning (HVAC) Control Systems
Accelerated Capital Allowances Eligibility Criteria Ref. No.: FAN C2.1 Category: Process and Heating, Ventilation and Air conditioning (HVAC) Control Systems Technology: Fans A fan is defined as a rotary
More informationCanadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines
Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials
More informationMEDICAL DEVICE. Technical file.
MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing
More informationLaboratorio di Tecnologie Biomediche
Laboratorio di Tecnologie Biomediche Introduction to medical devices Carmelo De Maria carmelo.demaria@unipi.it Medical Device A Medical Device is identified by means of its INTENDED PURPOSE Intended to
More informationDITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM
DITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM Satoshi Kimura DITTA Chair JIRA Executive Director IMDRF Stakeholder Forum Tokyo, 25 Mar. 2015 Key Topics Updates about DITTA DITTA views on current work items
More informationLeveraging Big Data to Mitigate Medical Device Risks. August 8, 2017
Leveraging Big Data to Mitigate Medical Device Risks August 8, 2017 Presenters Nicolas Tasse-Guillen Sr. Product Manager, Life Sciences Rachel Benway Assoc. Product Manager, Life Sciences A spotlight has
More informationManaging Supplies in an Operating Room Environment
Managing Supplies in an Operating Room Environment May 23, 2012 Meeting Key Objectives Understand the benefits of proper databases and how to build and maintain them Evaluate current state of the supplies
More informationChallenges for South African Medical Device Manufacturers
Challenges for South African Medical Device Manufacturers Malan De Villiers Chairman: MDMSA March 2017 www.mdmsa.co.za dmsasecretariat@mdmsa.co.za Local regulatory picture.. Medical Device companies face
More informationGLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Medical Device Product Questionnaire This questionnaire is used to collect information from vendors with regards to medical devices that fall in any of the
More informationJefferies London Healthcare Conference Julie Brown, CFO
Jefferies London Healthcare Conference Julie Brown, CFO Forward looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding
More informationAn Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs
An Introduction to the Worldwide Regulatory Framework for Medical Devices Elizabeth Malo M.S., Director, Regulatory Affairs Course Outline / Agenda» Overview Device Regulatory Framework» US/EU/Canada Premarket
More informationFDA Unique Device Identification (UDI) System. Readiness and Beyond
FDA Unique Device Identification (UDI) System Readiness and Beyond UDI: Global Scope In 2007, the US Congress passed legislation directing the Food and Drug Administration (FDA) to develop regulations
More informationYour complimentary Clinica Medtech Intelligence content
Your complimentary Clinica Medtech Intelligence content Clinica provides you with up to the minute coverage and opinion on company, product, market and regulatory developments as well as market size, growth
More informationGuidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order
Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order Document issued on: [Level 2, June 15, 2009] This guidance supersedes the document issued under this
More informationReady or Not: The New Medical Device Regulations Are Here!
Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional
More informationPost market Surveillance ISO EU Medical Device Regulation
Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes
More informationThe implications of the new EU Medical Device Regulation on Combination Product Packaging
The implications of the new EU Medical Device Regulation on Combination Product Packaging ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com A niche
More informationAre you on track for success?
Transitioning from a manual process to automated instrument management Are you on track for success? an ebook from Censis Technologies, Inc. Introduction It is well known that the HITECH Act (Health Information
More informationMedical Device Biocompatibility: ISO TC194 Overview & Standards
Medical Device Biocompatibility: ISO TC194 Overview & 10993 Standards Jon Cammack, PhD AstraZeneca/MedImmune R&D/Clinical Quality United States Head of Delegation (HoD), ISO TC194 Convenor, ISO TC194/WG15
More informationStreamlining IRB Procedures for Expanded Access
Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs
More informationSCOPE OF ACCREDITATION TO ISO/IEC 17025:2005. ELEMENT CINCINNATI 3701 Port Union Road Fairfield, Ohio Justin Riebesel Phone:
SCOPE OF ACCREDITATION TO ISO/IEC 17025:2005 ELEMENT CINCINNATI 3701 Port Union Road Fairfield, Ohio 45014 Justin Riebesel Phone: 513 771 2536 MECHANICAL Valid To: June 30, 2018 Certificate Number: 2422.01
More informationA REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE
BYLINED ARTICLE ON: A REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO 14971 COMPLIANCE By Mark Leimbeck PE Underwriters Laboratories and Larry Kessler Sc.D.
More informationThere are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction
There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction John F. Kennedy 12 May 1961 Annual Convention American for Democratic
More informationThe Device Side of Combination Products
The Device Side of Combination Products Technical and Regulatory Challenges in Life Cycle Management Bob Laughner Associate Director, Combination Products 04 May 2016 What are combination products? Combination
More informationCell Therapy Services Your Product. Our Passion.
Pharma&Biotech Cell Therapy Services Your Product. Our Passion. Complete Portfolio of Services for cgmp Manufacturing of Cell-based Products Pharma&Biotech Cell Therapy Services for cgmp Manufacturing
More informationCopyright GCI, LLC Remediation of Legacy Medical Devices
Copyright GCI, LLC. 2016 Remediation of Legacy Medical Devices Copyright GCI, LLC. 2016 What Drives Legacy Remediation? Proactive Recertification / CE Mark Audit Readiness M&A / Due Diligence Reactive
More informationUpdated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?
Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot? Introduc2on EU Medical Device Overview Current Medical Device Direc2ves ü Governed by 3 directives (past 15-20 yrs): Polling
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #21 (NQF 0268): Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalosporin National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL
More informationInVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury
1 Developing Innovative Products for Spinal Cord Injury 2 Forward-Looking Statements Before we begin, we would like to remind everyone that during our presentation, we will be making forward-looking statements
More informationUCI Medical Device Regulatory Awareness - Implications for Start-ups - Copyright 2017 Noblitt & Rueland. Contact Information.
UCI Medical Device Regulatory Awareness - Implications for Start-ups - Copyright 2017 Contact Information Mailing Address: 5405 Alton Parkway 5A, #530 Irvine, CA 92604-3718 Phone: (1) 949-398 398-5222
More informationHow to Get ISO Certified
People frequently ask me where to locate information about ISO 13485, so this whitepaper was written specifically to address their needs, as well as review in detail the six steps to preparing for ISO
More informationThe Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement
Page: 1 of 8 I. PURPOSE II. III. IV. The purpose of this Standard Operating Procedure is to delineate when an investigator must obtain an Investigational New Drug (IND) or Investigational Device Exemption
More informationUDI: The Ins and Outs of Global Compliance and Value
UDI: The Ins and Outs of Global Compliance and Value Karen Conway Executive Director GHX Jay Crowley Vice President USDM OMTEC 2015 Copyright 2015 by USDM Life Sciences Introductions Jay Crowley VP of
More informationAJRR Webinar ICD10-PCS guidance Unique Device Identifiers 2015
AJRR Webinar ICD10-PCS guidance Unique Device Identifiers 2015 AJRR Team Terra Miller Marketing Communications Kristine Baldwin Data Submission Analyst Randolph Meinzer - IT Director / Privacy Security
More informationC D R H. Computational Modeling in Medical Devices. Prasanna Hariharan, PhD
Computational Modeling in Medical Devices Prasanna Hariharan, PhD Office of Science and Engineering Laboratories Division of Solid and Fluid Mechanics Prasanna.hariharan@fda.hhs.gov C D R H ASME V&V Symposium
More informationEuropean Biocidal Products Forum A.I.S.E. & EBPF SURVEY BPR IMPACT ON BIOCIDAL PRODUCTS AND INNOVATION
European Biocidal Products Forum A.I.S.E. & EBPF SURVEY BPR IMPACT ON BIOCIDAL PRODUCTS AND INNOVATION Report December 2015 List of acronyms used in this report AS: Active Substance BP: Biocidal Product
More informationDan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President
Unique Device Identification Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-209-0600 1 Outline Medical Device Regulation
More informationA Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation
A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics
More informationHEALTH AND HUMAN SERVICES: HHS PROFILES
SMARTER STATE CASE STUDIES HEALTH AND HUMAN SERVICES: HHS PROFILES Using Expert Networking to Improve Safety and Efficiency of Medical Device Review TALENT BANK February 10, 2016 We would like to thank
More informationGuide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland
Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland AUT-G0095-1 15 AUGUST 2014 This guide does not purport to be an interpretation of law and/or regulations and is for
More informationwas published. February 21, 2017
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationWHITE PAPER. Everything You Need To Know About the FDA UDI Rule
Everything You Need To Know About the FDA UDI Rule Basics In creating the UDI system, the FDA aimed to reduce the burden on the healthcare industry by building on systems that are already in place. The
More informationUDI Guidance Document for Medical Devices Containing HCT/P
LEARNING UDI COMMUNITY UDI Guidance Document for Medical Devices Containing HCT/P WWW.AHRMM.ORG / LUC INTRODUCTION: Human cells, tissues, or cellular or tissue-based products (HCT/Ps) are a precious resource
More informationAdaptive Design for Medical Device Development
Adaptive Design for Medical Device Development A guide to accelerate clinical development and enhance portfolio value Executive Summary In May 2015, the FDA released a draft guidance document regarding
More informationVoluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program?
Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program? Cisco Vicenty Case for Quality Program Manager Center for Devices and Radiological Health U.S. Food and Drug Administration,
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationSurveillance and Medical Devices
Surveillance and Medical Devices Nicole Pratt Senior Research Fellow Medicine and Device Centre for Research Excellence Contact: Prof Libby Roughead UniSA, GPO Box 2471, Adelaide SA 5001 Libby.roughead@unisa.edu.au
More informationH-20 Page 1 of 5. Institutional Review Board Policy Manual HUMANITARIAN USE DEVICE (HUD) REQUIREMENTS
H-20 Page 1 of 5 Institutional Review Board Policy Manual HUMANITARIAN USE DEVICE (HUD) REQUIREMENTS PURPOSE: To describe the requirements for McLeod Health IRB review of Humanitarian Use Devices (HUD).
More informationGlobal Biomedical Metal Market
Market Report Global Biomedical Metal Market Third Edition Published: June, 2014 Publisher: Acmite Market Intelligence Language: English Pages: 575 Price: from 1,490 Euro Abstract Benefiting from robust
More informationExpanded Access. to Investigational Drugs & Biologics. for Treatment Use
SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use
More informationExpanded Access to Investigational Imaging Drugs
Expanded Access to Investigational Imaging Drugs Phillip B. Davis, MD FDA/CDER/ODEIV/DMIP 6/09/2016 1 Overview Expanded Access (EA) Defined Requirements for all EA authorizations Types of EA Individual
More informationMeso BioMatrix Acellular Peritoneum Matrix RECOMMENDED TECHNIQUE GUIDE. Recreating harmonious bodies for a new vision of rebirth.
Meso BioMatrix Acellular Peritoneum Matrix RECOMMENDED TECHNIQUE GUIDE Recreating harmonious bodies for a new vision of rebirth. 1 DISCOVER SEBBIN Sebbin is a 30 years-established company with a peerless
More informationUDI: From Compliance to Value OMTEC June 2013 Karen Conway
UDI: From Compliance to Value OMTEC June 2013 Karen Conway 1 GHX GHX proprietary information: Please do not not copy copy or or distribute UDI: The Reality UDI: The Reality UDI: The Reality UDI: The Reality
More information